Cargando…
Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer
Introduction. Carbonic anhydrase IX (CAIX) is a hypoxia regulated metalloenzyme integral to maintaining cellular pH. Increased CAIX expression is associated with poor prognosis in breast cancer. To explore CAIX as a biomarker for breast cancer therapies, we measured plasma CAIX levels in healthy con...
Autores principales: | Brown-Glaberman, Ursa, Marron, Marilyn, Chalasani, Pavani, Livingston, Robert, Iannone, Maria, Specht, Jennifer, Stopeck, Alison T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749816/ https://www.ncbi.nlm.nih.gov/pubmed/26941473 http://dx.doi.org/10.1155/2016/9810383 |
Ejemplares similares
-
A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer
por: Chalasani, Pavani, et al.
Publicado: (2015) -
Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
por: Brown-Glaberman, Ursa, et al.
Publicado: (2012) -
Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman, Ursa, et al.
Publicado: (2013) -
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer
por: Segar, Jennifer M., et al.
Publicado: (2019) -
Carbonic anhydrase IX in oligodendroglial brain tumors
por: Järvelä, Sally, et al.
Publicado: (2008)